Understanding Parkinson's Disease The more you know...
	Personalized treatment plans No single diagnosis will work for everybody
	Get a 2nd opinion Be sure about your care
	Parkinson's Research Institute Leading research to help you
	Our team Meet the experts
	Wisconsin Parkinson's Association
	Classes & support groups
	Contact us Let us know how we can help
	Return home Return to the Regional Parkinson's Center home page

Related links

	Doctors who can help Search for Aurora physicians that specialize in this field
	Related conditions   - Parkinson's disease

Parkinson's Research Institute

The Regional Parkinson's Center at Aurora Sinai Medical Center in Milwaukee is one of the largest centers of its kind in the U.S., seeing more than 100 patients per week. That give us an enormous database that can contribute to solving treatment issues, understanding the potential causes of Parkinson's disease and major research studies to better understand the long-term care implications of medications currently used to manage the symptoms of the disease.

The Regional Parkinson's Center is recognized as a Care Center by the National Parkinson's Foundation.

Clinical research

National research is a fundamental contributor to the overall goal of finding the cause and developing treatments for Parkinson's disease, essential tremor and other movement disorders. A number of potential treatments for Parkinson's disease now being evaluated in research centers show much promise:

• Neurotrophic proteins – these appear to protect nerve cells from the premature death that prompts Parkinson's disease.
  .
• Neuroprotective agents – researchers are examining naturally occurring compounds that appear to deactivate "free radicals," chemicals some scientists think may be linked to the damage of nerve cells in Parkinson's disease. New drug strategies are being designed to preserve dopamine cells.
  .
• Neural tissue transplants – researchers are studying ways to implant neural tissues from various sources into the brain to restore the damaged cells.
  .
• Genetic engineering – scientists are modifying the genetic code of an individual's cells to create dopamine-producing cells from other tissues, such as skin or muscle.
  .
• Timing and sequencing of levodopa and synthetic dopamine agonists – Parkinson's researchers are studying this issue to slow progression of the disease and reduce drug-related side effects.
  .
• Neurotoxins – identification and understanding of agents in the environment that can potentially damage the dopamine-producing area of the brain.

Charitable giving to the Parkinson's Research Institute

Gift arrangements will assist in supporting the Parkinson's Research Institute. Cash gifts, marketable securities and other gifts will be gratefully accepted. Some of these gifts include:

• Real estate and other tangible property
• Life insurance
• Estate and life income planning instruments – bequests, charitable remainder annuity trusts, charitable remainder unitrusts and life income contracts

Aurora Sinai's Philanthropy Program has professional expertise to assist prospective contributors with the development of such gifts and can explain the charitable benefits and tax consequences associated with each gift instrument.

All contributions and deferred commitments will be under the administration of Aurora Sinai Medical Center, a legally incorporated not-for-profit 501(c)(3) organization. Gifts will be restricted based upon their designated purpose and formally accounted using appropriate standards. Gifts to the Parkinson's Research Institute are tax-deductible to the full extent of the law.

Copyright Aurora Health Care, a Wisconsin-based health care provider.
3000 W. Montana St., Milwaukee, WI 53215, (414) 647-3000
Disclaimer | Privacy notice | Contact us
.